My long-term career goal is to become an independent investigator with the ability to apply molecular epidemiology methods, in the context of translational research, to gain better understanding of the factors and mechanisms related to lymphoma risk and prognosis. Recent literature reports a potential impact of vitamin D on improved prognosis in colorectal cancer, multiple myeloma, breast cancer, and most recently diffuse large B cell lymphoma (DLBCL) and chronic lymphocytic leukemia (CLL), two of the most prevalent non-Hodgkin lymphoma (NHL) subtypes. Building on my prior work on vitamin D and lymphoma etiology and these promising findings, I plan to further evaluate the role of vitamin D in lymphoma prognosis, with a focus on the two most common NHL subtypes, DLBCL and follicular lymphoma (FL). We propose to: 1) determine whether sun exposure, dietary vitamin D intake, and vitamin D related germline variations are associated with DLBCL prognosis;2) evaluate whether pre-treatment circulating vitamin D (serum 25(OH)D) is associated with FL prognosis;and 3) correlate levels of serum 25(OH)D with levels of cell cycle regulation and apoptosis protein markers within paired DLBCL and FL tumor samples. I have designed a career development training curriculum and tailored my research plan to obtain: 1) specialized didactic training in molecular epidemiology methods;2) practical experience in innovative translational research hypothesis generation, project design, relevant statistical analysis, and communication of results;3) development of leadership and management skills necessary to run a successful and effective research team;and 4) enhanced understanding of clinical and therapeutic aspects of lymphoma. To accomplish the proposed research aims, I have established a collaboration between the University of Rochester (UR) Lymphoma SPORE and the University of Iowa/Mayo Clinic (UI/MC) Lymphoma SPORE, and have secured access to a large cohort of DLBCL patients in the UI/MC Lymphoma SPORE's ongoing Molecular Epidemiology Resource. Furthermore, I have established a collaboration with the Southwest Oncology Group to access a cohort of uniformly treated FL patients for Aim 2, and we will be able to address Aim 3 within the UR Lymphoma SPORE Tissue Repository. Implementation of this plan and progress towards my goals will be monitored regularly throughout the duration of the proposed project period by a team of four experienced investigators (Jonathan Friedberg, primary mentor, clinical expertise;James Cerhan, co-mentor, molecular and genetic epidemiology expertise;Steve Bernstein, co-mentor, lymphoma biology expertise;and Derick Peterson, co-mentor, biostatistics expertise), selected specifically for their unique expertise relevant to my career development objectives and research plan. The research proposed addresses an important question, in a priority area, and promises to be a relevant contribution to the literature upon completion.

Public Health Relevance

Non-Hodgkin lymphoma (NHL) is the 6th most common cancer in the United States. There are an estimated 20,000 annual NHL deaths, though epidemiology of NHL prognosis remains poorly understood. Vitamin D is a modifiable lifestyle factor, and closer evaluation of its role in NHL prognosis is warranted.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Academic/Teacher Award (ATA) (K07)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Program Officer
Perkins, Susan N
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Rochester
Internal Medicine/Medicine
Schools of Dentistry
United States
Zip Code
Biswas, Tithi; Culakova, Eva; Friedberg, Jonathan W et al. (2012) Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphoma. Radiother Oncol 103:367-72
Kelly, Jennifer L; Drake, Matthew T; Fredericksen, Zachary S et al. (2012) Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma. Cancer Causes Control 23:1017-29
Ban-Hoefen, Makiko; Kelly, Jennifer L; Bernstein, Steven H et al. (2012) High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era. Leuk Lymphoma 53:830-5
Keller, Sarah F; Kelly, Jennifer L; Sensenig, Elizabeth et al. (2012) Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic era. Biol Blood Marrow Transplant 18:640-7
Kelly, Jennifer L; Fredericksen, Zachary S; Liebow, Mark et al. (2012) The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender. Ann Epidemiol 22:855-62